Cowen and Company’s SomaLogic, Inc. Class A Common Stock SLGC Stock Holding History

Cowen and Company’s Portfolio SLGC Stock Details SLGC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-247,226	Closed	-$625K	–	804
2023 Q4	$625K	Hold	247,226	–	–	0.04%	174
2023 Q3	$591K	Hold	247,226	–	–	0.04%	164
2023 Q2	$571K	Hold	247,226	–	–	0.05%	173
2023 Q1	$630K	Hold	247,226	–	–	0.07%	106
2022 Q4	$621K	Hold	247,226	–	–	0.06%	117
2022 Q3	$717K	Hold	247,226	–	–	0.07%	97
2022 Q2	$1.12M	Hold	247,226	–	–	0.11%	91
2022 Q1	$1.98M	Hold	247,226	–	–	0.19%	67
2021 Q4	$2.88M	Hold	247,226	–	–	0.26%	83
2021 Q3	$3.06M	Buy	+247,226	New	+$2.79M	0.15%	67

Cowen and Company's SLGC Position: Q1 2024 in Review

Cowen and Company sold out of SomaLogic, Inc. Class A Common Stock (SLGC) in Q1 2024, closing a stake of 247,226 shares — an estimated $625K sold.

Cowen and Company first reported a position in SLGC in Q3 2021 and held it in 10 quarters. The position peaked at $3.06M in Q3 2021. 0 funds tracked by Wall St. Rank hold SLGC as of Q1 2024.

Cowen and Company reported no remaining SomaLogic, Inc. Class A Common Stock position as of Q1 2024 after selling out during the quarter.
Cowen and Company sold 247,226 SomaLogic, Inc. Class A Common Stock shares in Q1 2024, an estimated $625K.
Cowen and Company first reported a position in SomaLogic, Inc. Class A Common Stock in Q3 2021 and held it in 10 quarters.
Cowen and Company's SomaLogic, Inc. Class A Common Stock position peaked at $3.06M in Q3 2021.
0 funds tracked by Wall St. Rank held SomaLogic, Inc. Class A Common Stock as of Q1 2024.

Based on Cowen and Company's 13F filing for Q1 2024, filed 3 May 2024.